Morning Rounds \u00b7 Pharmacokinetics \u00b7 Round 06<\/title>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Playfair+Display:ital,wght@0,400;0,600;0,700;1,400;1,600&family=Source+Serif+4:ital,wght@0,300;0,400;0,600;1,400&display=swap\" rel=\"stylesheet\">\n<style>\n#npk06 *,#npk06 *::before,#npk06 *::after{box-sizing:border-box;margin:0;padding:0}\n#npk06{\n --ob:#1A5F7A;--ob-light:#236E8C;--ob-pale:#E6F3F7;--ob-dark:#114455;\n --correct:#2D6B47;--correct-bg:#EAF6EF;--correct-border:#3A9960;\n --wrong:#B83232;--wrong-bg:#FDF0F0;--wrong-border:#E53935;\n --ink:#0F2A35;--ink-mid:#2A4D5A;--ink-soft:#5A7D8A;\n --line:#B8D8E3;--cream:#F2F8FA;--warm:#F8FCFD;\n font-family:'Source Serif 4',Georgia,serif;\n font-size:16px;color:var(--ink);background:var(--cream);\n line-height:1.7;padding:0 0 64px;\n}\n#npk06 .mr-header{background:linear-gradient(135deg,var(--ob-dark) 0%,var(--ob) 60%,var(--ob-light) 100%);color:#E4F4F9;padding:36px 24px 30px;text-align:center;position:relative;overflow:hidden;}\n#npk06 .mr-header::before{content:'';position:absolute;inset:0;background:repeating-linear-gradient(45deg,transparent,transparent 18px,rgba(255,255,255,0.03) 18px,rgba(255,255,255,0.03) 19px);}\n#npk06 .mr-eyebrow{font-size:0.66rem;letter-spacing:0.22em;text-transform:uppercase;font-weight:700;opacity:0.6;margin-bottom:10px;position:relative;}\n#npk06 .mr-series-tag{display:inline-block;background:rgba(255,255,255,0.12);border:1px solid rgba(255,255,255,0.2);border-radius:4px;padding:2px 10px;font-size:0.64rem;letter-spacing:0.14em;text-transform:uppercase;font-weight:700;margin-bottom:14px;position:relative;}\n#npk06 .mr-title{font-family:'Playfair Display',serif;font-size:1.8rem;font-weight:700;line-height:1.2;margin-bottom:6px;position:relative;}\n#npk06 .mr-title em{font-style:italic;font-weight:400;opacity:0.85}\n#npk06 .mr-subtitle{font-size:0.82rem;opacity:0.65;margin-top:8px;font-style:italic;position:relative;}\n#npk06 .mr-chips{display:flex;justify-content:center;gap:10px;margin-top:18px;flex-wrap:wrap;position:relative;}\n#npk06 .mr-chip{background:rgba(255,255,255,0.13);border:1px solid rgba(255,255,255,0.22);border-radius:20px;padding:4px 13px;font-size:0.72rem;}\n#npk06 .mr-sentinel{height:1px}\n#npk06 .mr-progress{position:fixed;top:0;left:0;right:0;z-index:9999;background:var(--warm);border-bottom:1px solid var(--line);box-shadow:0 2px 12px rgba(15,42,53,0.1);padding:9px 16px;display:none;}\n#npk06 .mr-progress.visible{display:block}\n#npk06 .mr-prog-inner{max-width:720px;margin:0 auto;display:flex;align-items:center;justify-content:center}\n#npk06 .mr-pips{display:flex;align-items:center;justify-content:center}\n#npk06 .mr-pip-wrap{display:flex;align-items:center}\n#npk06 .mr-pip-line{width:28px;height:2px;background:var(--line);transition:background 0.35s}\n#npk06 .mr-pip-line.done{background:var(--ob)}\n#npk06 .mr-pip{width:28px;height:28px;border-radius:50%;border:2px solid var(--line);background:var(--warm);display:flex;align-items:center;justify-content:center;font-size:0.63rem;font-weight:700;color:var(--ink-soft);transition:all 0.3s;flex-shrink:0;}\n#npk06 .mr-pip.correct{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#npk06 .mr-pip.wrong{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#npk06 .mr-body{max-width:720px;margin:0 auto;padding:0 16px}\n#npk06 .mr-case{background:var(--warm);border:1px solid var(--line);border-left:4px solid var(--ob);border-radius:10px;margin:28px 0;overflow:hidden;box-shadow:0 1px 8px rgba(15,42,53,0.07);}\n#npk06 .mr-case-top{padding:16px 20px 14px;display:flex;gap:14px;align-items:flex-start}\n#npk06 .mr-num{font-family:'Playfair Display',serif;font-size:2.2rem;font-weight:700;color:var(--ob);opacity:0.14;line-height:1;margin-top:-2px;flex-shrink:0;}\n#npk06 .mr-meta{flex:1}\n#npk06 .mr-tag{font-size:0.61rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;color:var(--ob);opacity:0.8;margin-bottom:5px;}\n#npk06 .mr-stem{font-size:0.94rem;color:var(--ink);line-height:1.72}\n#npk06 .mr-stem strong{font-weight:600}\n#npk06 .mr-stem em{font-style:italic}\n#npk06 .mr-rule{height:1px;background:var(--line);margin:0 20px}\n#npk06 .mr-opts{padding:12px 20px 16px;display:flex;flex-direction:column;gap:8px}\n#npk06 .mr-opt{display:flex;align-items:flex-start;gap:11px;padding:10px 14px;border:1.5px solid var(--line);border-radius:8px;cursor:pointer;background:var(--warm);transition:border-color 0.15s,background 0.15s;-webkit-tap-highlight-color:transparent;}\n#npk06 .mr-opt:hover{border-color:var(--ob);background:var(--ob-pale)}\n#npk06 .mr-opt.locked{cursor:default}\n#npk06 .mr-opt.locked:hover{border-color:var(--line);background:var(--warm)}\n#npk06 .mr-opt.correct{border-color:var(--correct-border);background:var(--correct-bg);cursor:default}\n#npk06 .mr-opt.correct:hover{border-color:var(--correct-border);background:var(--correct-bg)}\n#npk06 .mr-opt.wrong{border-color:var(--wrong-border);background:var(--wrong-bg);cursor:default}\n#npk06 .mr-opt.wrong:hover{border-color:var(--wrong-border);background:var(--wrong-bg)}\n#npk06 .mr-opt.dimmed{opacity:0.35;cursor:default}\n#npk06 .mr-opt.dimmed:hover{border-color:var(--line);background:var(--warm)}\n#npk06 .mr-ltr{flex-shrink:0;width:20px;height:20px;border-radius:50%;border:1.5px solid var(--line);display:flex;align-items:center;justify-content:center;font-size:0.62rem;font-weight:700;color:var(--ink-soft);margin-top:2px;transition:all 0.15s;}\n#npk06 .mr-opt.correct .mr-ltr{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#npk06 .mr-opt.wrong .mr-ltr{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#npk06 .mr-opt-text{font-size:0.9rem;color:var(--ink-mid);line-height:1.58}\n#npk06 .mr-opt.correct .mr-opt-text{color:var(--correct);font-weight:600}\n#npk06 .mr-opt.wrong .mr-opt-text{color:var(--wrong)}\n#npk06 .mr-exp{display:none;border-top:1px solid #9CCFDF;background:linear-gradient(180deg,#D4EEF7 0%,#EAF5FA 100%);padding:13px 20px 15px;}\n#npk06 .mr-exp-lbl{font-size:0.61rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;color:var(--ob-dark);margin-bottom:6px;}\n#npk06 .mr-exp-text{font-size:0.86rem;color:#0F2A35;line-height:1.7}\n#npk06 .mr-exp-text strong{font-weight:600}\n#npk06 .mr-exp-text em{font-style:italic}\n#npk06 .mr-exp-text .calc{display:block;background:rgba(26,95,122,0.08);border-left:3px solid var(--ob);border-radius:0 4px 4px 0;padding:6px 10px;margin:8px 0;font-family:Georgia,serif;font-size:0.84rem;color:var(--ob-dark);}\n#npk06 .mr-submit-wrap{text-align:center;padding:28px 16px 8px}\n#npk06 .mr-btn{background:var(--ob);color:#E4F4F9;border:none;border-radius:8px;padding:13px 44px;font-family:'Playfair Display',serif;font-size:1rem;font-weight:700;cursor:pointer;box-shadow:0 2px 10px rgba(26,95,122,0.32);}\n#npk06 .mr-btn:hover{background:var(--ob-dark)}\n#npk06 .mr-score{display:none;background:var(--warm);border:1px solid var(--line);border-top:4px solid var(--ob);border-radius:10px;margin:24px 0 0;box-shadow:0 2px 12px rgba(15,42,53,0.08);overflow:hidden;}\n#npk06 .mr-score-in{padding:28px 24px;text-align:center}\n#npk06 .mr-score-ey{font-size:0.66rem;letter-spacing:0.14em;text-transform:uppercase;color:var(--ink-soft);margin-bottom:12px;font-weight:600;}\n#npk06 .mr-ring{width:98px;height:98px;border-radius:50%;background:conic-gradient(var(--ob) 0%,var(--line) 0%);display:flex;align-items:center;justify-content:center;margin:0 auto 16px;position:relative;}\n#npk06 .mr-ring::before{content:'';position:absolute;width:76px;height:76px;border-radius:50%;background:var(--warm);}\n#npk06 .mr-ring-in{position:relative;display:flex;flex-direction:column;align-items:center;line-height:1.2}\n#npk06 .mr-ring-pct{font-family:'Playfair Display',serif;font-size:1.3rem;font-weight:700;color:var(--ob)}\n#npk06 .mr-ring-sub{font-size:0.54rem;color:var(--ink-soft);text-transform:uppercase;letter-spacing:0.06em}\n#npk06 .mr-score-title{font-family:'Playfair Display',serif;font-size:1.15rem;font-weight:700;color:var(--ink);margin-bottom:4px}\n#npk06 .mr-score-net{font-size:0.9rem;color:var(--ob);font-weight:600;margin-bottom:4px}\n#npk06 .mr-verdict{font-size:0.83rem;color:var(--ink-soft);font-style:italic;margin-bottom:18px;padding:0 12px}\n#npk06 .mr-bands{display:flex;justify-content:center;gap:10px;flex-wrap:wrap}\n#npk06 .mr-band{padding:5px 13px;border-radius:16px;font-size:0.78rem;font-weight:600}\n#npk06 .mr-band-c{background:var(--correct-bg);color:var(--correct)}\n#npk06 .mr-band-w{background:var(--wrong-bg);color:var(--wrong)}\n#npk06 .mr-band-s{background:var(--ob-pale);color:var(--ob)}\n#npk06 .mr-retry{display:block;margin:18px auto 4px;background:transparent;border:2px solid var(--ob);color:var(--ob);border-radius:8px;padding:9px 28px;font-family:'Playfair Display',serif;font-size:0.92rem;font-weight:700;cursor:pointer;}\n#npk06 .mr-retry:hover{background:var(--ob);color:#E4F4F9}\n@media(max-width:480px){\n #npk06 .mr-title{font-size:1.4rem}\n #npk06 .mr-num{font-size:1.7rem}\n #npk06 .mr-stem{font-size:0.9rem}\n #npk06 .mr-opt-text{font-size:0.86rem}\n}\n<\/style>\n\n<div id=\"npk06\">\n\n <div class=\"mr-header\">\n <div class=\"mr-series-tag\">Numerical Series · Pharmacokinetics<\/div>\n <div class=\"mr-eyebrow\">Morning Rounds · Round 06 of 07<\/div>\n <div class=\"mr-title\">Mixed Clinical<br><em>Numericals<\/em><\/div>\n <div class=\"mr-subtitle\">Five scenarios · All concepts integrated — the way examiners actually ask them<\/div>\n <div class=\"mr-chips\">\n <span class=\"mr-chip\">5 Questions<\/span>\n <span class=\"mr-chip\">+4 \/ −1 scoring<\/span>\n <span class=\"mr-chip\">Options reshuffled<\/span>\n <\/div>\n <\/div>\n\n <div class=\"mr-sentinel\" id=\"npk06-sentinel\"><\/div>\n\n <div class=\"mr-progress\" id=\"npk06-progress\">\n <div class=\"mr-prog-inner\">\n <div class=\"mr-pips\" id=\"npk06-pips\"><\/div>\n <\/div>\n <\/div>\n\n <div class=\"mr-body\">\n <div id=\"npk06-cases\"><\/div>\n <div class=\"mr-submit-wrap\">\n <button class=\"mr-btn\" id=\"npk06-submit\">Submit for Debrief<\/button>\n <\/div>\n <div class=\"mr-score\" id=\"npk06-score\">\n <div class=\"mr-score-in\">\n <div class=\"mr-score-ey\">Round Complete<\/div>\n <div class=\"mr-ring\" id=\"npk06-ring\">\n <div class=\"mr-ring-in\">\n <span class=\"mr-ring-pct\" id=\"npk06-pct\">0%<\/span>\n <span class=\"mr-ring-sub\">net<\/span>\n <\/div>\n <\/div>\n <div class=\"mr-score-title\">Your Debrief<\/div>\n <div class=\"mr-score-net\" id=\"npk06-net\"><\/div>\n <div class=\"mr-verdict\" id=\"npk06-verdict\"><\/div>\n <div class=\"mr-bands\">\n <span class=\"mr-band mr-band-c\" id=\"npk06-ct-c\"><\/span>\n <span class=\"mr-band mr-band-w\" id=\"npk06-ct-w\"><\/span>\n <span class=\"mr-band mr-band-s\" id=\"npk06-ct-s\"><\/span>\n <\/div>\n <button class=\"mr-retry\" id=\"npk06-retry\">↻ New Round<\/button>\n <\/div>\n <\/div>\n <\/div>\n\n<\/div>\n\n<script>\n(function () {\n 'use strict';\n\n var NS = 'npk06';\n var TOTAL = 5;\n var MAX = 20;\n var LTRS = ['A','B','C','D'];\n\n var QS = [\n\n {\n id: 1,\n tag: 'Clinical Scenario — Digoxin Toxicity & Vd',\n stem: 'A 68-year-old man on digoxin develops toxicity. His plasma digoxin level is <strong>4 ng\/mL<\/strong> (toxic). Digoxin has a Vd of <strong>500 L<\/strong> and a half-life of <strong>36 hours<\/strong>. A colleague suggests urgent haemodialysis. You disagree. What is the total amount of digoxin in the body, and why is haemodialysis futile?',\n correct: '2000 mcg in the body; haemodialysis is futile because with Vd of 500 L, less than 1% of total body digoxin resides in plasma at any time \u2014 dialysis cannot access tissue-bound drug',\n opts: [\n '2000 mcg in the body; haemodialysis is futile because with Vd of 500 L, less than 1% of total body digoxin resides in plasma at any time \u2014 dialysis cannot access tissue-bound drug',\n '4 mcg in the body; haemodialysis is appropriate because the plasma concentration directly reflects total body burden and dialysis clears plasma efficiently',\n '2000 mcg in the body; haemodialysis is appropriate because digoxin\\'s long half-life of 36 hours means spontaneous elimination is too slow to be clinically useful',\n '200 mcg in the body; haemodialysis is futile but the correct treatment is forced diuresis to accelerate renal excretion of the plasma fraction'\n ],\n exp: 'First, calculate total body burden:<span class=\"calc\">Total drug = C<sub>p<\/sub> × Vd<br>= 4 ng\/mL × 500 L<br>= 4 ng\/mL × 500,000 mL<br>= 2,000,000 ng = <strong>2000 mcg = 2 mg<\/strong><\/span>Now ask: how much is in plasma?<span class=\"calc\">Plasma volume ≈ 3 L<br>Drug in plasma = 4 ng\/mL × 3000 mL = 12,000 ng = <strong>12 mcg<\/strong><br>That is 12 ÷ 2000 = <strong>0.6% of total body digoxin<\/strong><\/span>Haemodialysis filters plasma. With 99.4% of digoxin buried in tissues, dialysis removes a clinically irrelevant fraction. The correct treatment is <strong>digoxin-specific antibody fragments (Digibind\/DigiFab)<\/strong>, which bind digoxin in tissues and plasma, pulling it back into circulation for renal elimination. This question integrates Vd, unit conversion, and clinical reasoning in one scenario — exactly how exam writers think.'\n },\n\n {\n id: 2,\n tag: 'Clinical Scenario — Maintenance Dose Calculation',\n stem: 'A patient requires a plasma theophylline concentration of <strong>10 mg\/L<\/strong> at steady state. Theophylline clearance in this patient is <strong>40 mL\/min<\/strong> and its oral bioavailability is <strong>100%<\/strong>. What oral maintenance dose (in mg\/hour) is required?',\n correct: '24 mg\/hour',\n opts: [\n '24 mg\/hour',\n '400 mg\/hour',\n '0.4 mg\/hour',\n '14.4 mg\/hour'\n ],\n exp: 'Maintenance dose formula:<span class=\"calc\">Maintenance dose = C<sub>ss<\/sub> × CL ÷ F<br>where F = bioavailability (1.0 here)<\/span>Units first — the trap:<span class=\"calc\">CL = 40 mL\/min × 60 min\/hr = 2400 mL\/hr = <strong>2.4 L\/hr<\/strong><br><br>Maintenance dose = 10 mg\/L × 2.4 L\/hr ÷ 1.0<br>= <strong>24 mg\/hour<\/strong><\/span>Trap 400 mg\/hour comes from forgetting to convert mL to L (using 2400 instead of 2.4). Trap 0.4 mg\/hour divides instead of multiplies. Trap 14.4 mg\/hour uses 24 mL\/min (wrong conversion) × 0.6. The units conversion — mL\/min to L\/hr — is the entire exam point, identical to the infusion trap in R4. Examiners return to this well repeatedly because it catches the candidate who knows the formula but rushes the arithmetic.'\n },\n\n {\n id: 3,\n tag: 'Clinical Scenario — Phenytoin & Non-linear Kinetics',\n stem: 'A patient on phenytoin <strong>300 mg\/day<\/strong> has a plasma level of <strong>8 mg\/L<\/strong> (subtherapeutic; target 10–20 mg\/L). The dose is increased to <strong>400 mg\/day<\/strong>. Two weeks later the plasma level is <strong>24 mg\/L<\/strong> (toxic). Which pharmacokinetic property of phenytoin explains this disproportionate rise?',\n correct: 'Phenytoin follows Michaelis-Menten (saturation) kinetics; near therapeutic doses its metabolic enzymes are near-saturated, so a small dose increase causes a disproportionately large rise in plasma concentration',\n opts: [\n 'Phenytoin follows Michaelis-Menten (saturation) kinetics; near therapeutic doses its metabolic enzymes are near-saturated, so a small dose increase causes a disproportionately large rise in plasma concentration',\n 'Phenytoin has a narrow therapeutic index and the dose increase exceeded the LD50, causing toxic plasma levels through first-order accumulation',\n 'Phenytoin induces its own metabolism (autoinduction) at higher doses, paradoxically increasing plasma levels by generating toxic metabolites rather than clearing the parent compound',\n 'The rise is explained by zero-order kinetics at all phenytoin doses; a fixed absolute amount is always eliminated, so adding 100 mg\/day always raises steady state by a fixed predictable amount'\n ],\n exp: 'Phenytoin is the <em>classic<\/em> Michaelis-Menten drug. At low doses it behaves like first-order kinetics — enzymes not saturated, concentration proportional to dose. But near therapeutic levels, hepatic hydroxylation enzymes approach <strong>saturation<\/strong>.<span class=\"calc\">At saturation: elimination rate becomes fixed (zero-order-like)<br>Adding 100 mg\/day to an already-saturated system<br>= enzyme cannot keep up<br>= drug accumulates disproportionately<\/span>The dose increased by 33% (300 → 400 mg\/day). The plasma level increased by 200% (8 → 24 mg\/L). This <strong>non-linear<\/strong> response is the pharmacokinetic signature of Michaelis-Menten kinetics. Clinical rule: <strong>phenytoin dose adjustments must be small (25–50 mg increments) and levels rechecked after 2 weeks<\/strong>. Other MM drugs: aspirin (high dose), alcohol. Trap D is wrong: zero-order gives a <em>predictable<\/em> fixed rise — the unpredictability here is the whole point.'\n },\n\n {\n id: 4,\n tag: 'Clinical Scenario — Two-Compartment Kinetics',\n stem: 'An anaesthetist gives a single IV bolus of thiopentone. The patient loses consciousness within 30 seconds but wakes up in <strong>5–10 minutes<\/strong>, even though thiopentone has a terminal half-life of <strong>11 hours<\/strong>. The rapid recovery is best explained by:',\n correct: 'Rapid redistribution of thiopentone from the brain (central compartment) into muscle and fat (peripheral compartments), causing plasma and brain concentrations to fall below the threshold for unconsciousness despite the drug still being present in the body',\n opts: [\n 'Rapid redistribution of thiopentone from the brain (central compartment) into muscle and fat (peripheral compartments), causing plasma and brain concentrations to fall below the threshold for unconsciousness despite the drug still being present in the body',\n 'Rapid hepatic metabolism of thiopentone by CYP enzymes, eliminating the drug within minutes and explaining both the short duration of action and the 11-hour half-life being a measurement artefact',\n 'Active transport of thiopentone out of the CNS by P-glycoprotein efflux pumps at the blood-brain barrier, rapidly clearing the drug from the brain while total body burden remains unchanged',\n 'Tachyphylaxis to thiopentone developing within minutes of administration, causing GABA receptors in the brain to become desensitised and restoring consciousness before the drug is eliminated'\n ],\n exp: 'This is the <strong>redistribution phenomenon<\/strong> — one of the most elegant concepts in clinical pharmacokinetics.<br><br>After IV bolus, thiopentone rapidly enters the <strong>brain<\/strong> (highly perfused, lipophilic drug crosses BBB instantly) → unconsciousness. But the drug then <strong>redistributes<\/strong> from brain into <strong>muscle<\/strong> (large mass, moderately perfused) and eventually into <strong>fat<\/strong> (large mass, poorly perfused but high lipid affinity).<span class=\"calc\">Brain concentration falls → below anaesthetic threshold → patient wakes<br>Total body drug: unchanged (barely any eliminated in 10 min)<br>Terminal t½ 11 hrs = slow release back from fat + eventual hepatic metabolism<\/span>This two-compartment behaviour explains why thiopentone is used for <strong>induction only<\/strong>, not maintenance. The same principle explains why a single dose of diazepam has a shorter clinical effect than its 20–100 hour half-life would predict. Trap B is wrong: hepatic metabolism plays no role in the rapid offset. This is purely a distribution phenomenon.'\n },\n\n {\n id: 5,\n tag: 'Clinical Scenario — Bioavailability & Route Comparison',\n stem: 'A patient receives <strong>200 mg of drug X orally<\/strong> and achieves a peak plasma AUC of <strong>800 mg·hr\/L<\/strong>. The same patient receives <strong>100 mg IV<\/strong> and achieves an AUC of <strong>1000 mg·hr\/L<\/strong>. What is the <strong>oral bioavailability<\/strong> of Drug X?',\n correct: '40%',\n opts: [\n '40%',\n '80%',\n '125%',\n '50%'\n ],\n exp: 'Bioavailability (F) formula:<span class=\"calc\">F = (AUC<sub>oral<\/sub> ÷ Dose<sub>oral<\/sub>) ÷ (AUC<sub>IV<\/sub> ÷ Dose<sub>IV<\/sub>)<br><br>= (800 ÷ 200) ÷ (1000 ÷ 100)<br>= 4 ÷ 10<br>= <strong>0.40 = 40%<\/strong><\/span>The critical step: <strong>dose-normalise both AUCs before dividing<\/strong>. The doses are different (200 mg oral vs 100 mg IV), so raw AUC cannot be directly compared. Trap B (80%) comes from dividing 800 by 1000 without dose normalisation — the most common error. Trap C (125%) inverts the ratio after dose normalisation. Trap D (50%) divides 100 by 200 (the doses) without involving AUC at all.<br><br>Bioavailability of 40% is clinically significant: it means <strong>60% of the oral dose is lost<\/strong> to first-pass metabolism, gut wall metabolism, or incomplete absorption. To achieve the same systemic exposure as 100 mg IV, you would need 100 ÷ 0.40 = <strong>250 mg orally<\/strong>.'\n }\n\n ];\n\n var answers = {}, answered = 0, shuffled = {}, done = false;\n\n function gid(s) { return document.getElementById(NS + '-' + s); }\n function byId(s) { return document.getElementById(s); }\n\n function shuffleArr(arr) {\n var a = arr.slice(), i, j, t;\n for (i = a.length - 1; i > 0; i--) {\n j = Math.floor(Math.random() * (i + 1));\n t = a[i]; a[i] = a[j]; a[j] = t;\n }\n return a;\n }\n\n function countVal(v) {\n var n = 0, k;\n for (k in answers) { if (answers[k] === v) n++; }\n return n;\n }\n\n function buildPips() {\n var cont = gid('pips'), i, q, wLine, wPip, line, pip;\n cont.innerHTML = '';\n for (i = 0; i < QS.length; i++) {\n q = QS[i];\n if (i > 0) {\n wLine = document.createElement('div');\n wLine.className = 'mr-pip-wrap';\n line = document.createElement('div');\n line.className = 'mr-pip-line';\n line.id = NS + '-pl' + q.id;\n wLine.appendChild(line);\n cont.appendChild(wLine);\n }\n wPip = document.createElement('div');\n wPip.className = 'mr-pip-wrap';\n pip = document.createElement('div');\n pip.className = 'mr-pip';\n pip.id = NS + '-pip' + q.id;\n pip.textContent = String(q.id);\n wPip.appendChild(pip);\n cont.appendChild(wPip);\n }\n }\n\n function build() {\n var cont, i, q, opts, card, top, numDiv, meta, tag, stem,\n rule, optsDiv, expDiv, lbl, txt, j, optEl, ltrSpan, txtSpan;\n\n cont = gid('cases');\n cont.innerHTML = '';\n answers = {}; answered = 0; shuffled = {}; done = false;\n gid('score').style.display = 'none';\n buildPips();\n\n for (i = 0; i < QS.length; i++) {\n q = QS[i];\n opts = shuffleArr(q.opts);\n shuffled[q.id] = opts;\n\n card = document.createElement('div');\n card.className = 'mr-case';\n\n top = document.createElement('div');\n top.className = 'mr-case-top';\n\n numDiv = document.createElement('div');\n numDiv.className = 'mr-num';\n numDiv.textContent = q.id < 10 ? '0' + q.id : String(q.id);\n\n meta = document.createElement('div');\n meta.className = 'mr-meta';\n\n tag = document.createElement('div');\n tag.className = 'mr-tag';\n tag.innerHTML = q.tag;\n\n stem = document.createElement('div');\n stem.className = 'mr-stem';\n stem.innerHTML = q.stem;\n\n meta.appendChild(tag);\n meta.appendChild(stem);\n top.appendChild(numDiv);\n top.appendChild(meta);\n card.appendChild(top);\n\n rule = document.createElement('div');\n rule.className = 'mr-rule';\n card.appendChild(rule);\n\n optsDiv = document.createElement('div');\n optsDiv.className = 'mr-opts';\n\n for (j = 0; j < opts.length; j++) {\n optEl = document.createElement('div');\n optEl.className = 'mr-opt';\n optEl.id = NS + '-o' + q.id + '-' + j;\n optEl.setAttribute('role', 'button');\n optEl.setAttribute('tabindex', '0');\n\n ltrSpan = document.createElement('span');\n ltrSpan.className = 'mr-ltr';\n ltrSpan.textContent = LTRS[j];\n\n txtSpan = document.createElement('span');\n txtSpan.className = 'mr-opt-text';\n txtSpan.innerHTML = opts[j];\n\n optEl.appendChild(ltrSpan);\n optEl.appendChild(txtSpan);\n optsDiv.appendChild(optEl);\n\n (function (qid, oi) {\n optEl.addEventListener('click', function () { pick(qid, oi); });\n }(q.id, j));\n }\n card.appendChild(optsDiv);\n\n expDiv = document.createElement('div');\n expDiv.className = 'mr-exp';\n expDiv.id = NS + '-exp' + q.id;\n\n lbl = document.createElement('div');\n lbl.className = 'mr-exp-lbl';\n lbl.textContent = 'Debrief';\n\n txt = document.createElement('div');\n txt.className = 'mr-exp-text';\n txt.innerHTML = q.exp;\n\n expDiv.appendChild(lbl);\n expDiv.appendChild(txt);\n card.appendChild(expDiv);\n cont.appendChild(card);\n }\n }\n\n function pick(qid, oi) {\n var q, opts, i, el, correct;\n if (answers[qid] !== undefined || done) return;\n\n q = null;\n for (i = 0; i < QS.length; i++) {\n if (QS[i].id === qid) { q = QS[i]; break; }\n }\n if (!q) return;\n\n opts = shuffled[qid];\n correct = (opts[oi] === q.correct);\n answers[qid] = correct ? 'c' : 'w';\n answered++;\n\n for (i = 0; i < opts.length; i++) {\n el = byId(NS + '-o' + qid + '-' + i);\n if (opts[i] === q.correct) {\n el.className = 'mr-opt correct locked';\n } else if (i === oi) {\n el.className = 'mr-opt wrong locked';\n } else {\n el.className = 'mr-opt dimmed locked';\n }\n }\n\n byId(NS + '-exp' + qid).style.display = 'block';\n byId(NS + '-pip' + qid).className = 'mr-pip ' + (correct ? 'correct' : 'wrong');\n\n if (qid > 1) {\n var pl = byId(NS + '-pl' + qid);\n if (pl) { pl.className = 'mr-pip-line done'; }\n }\n }\n\n function showScore() {\n var c, w, s, net, pct, disp, verdicts, vi, sc;\n if (done) return;\n done = true;\n\n c = countVal('c');\n w = countVal('w');\n s = TOTAL - answered;\n net = (c * 4) - w;\n pct = Math.max(0, Math.round((net \/ MAX) * 100));\n disp = Math.min(100, Math.max(0, pct));\n\n gid('ring').style.background =\n 'conic-gradient(#1A5F7A ' + disp + '%, #B8D8E3 0%)';\n\n gid('pct').textContent = pct + '%';\n gid('net').textContent = 'Net Score: ' + net + ' \/ ' + MAX;\n\n verdicts = [\n [5, 'Flawless. Digoxin toxicity, phenytoin saturation, thiopentone redistribution, bioavailability \\u2014 all integrated cleanly.'],\n [4, 'Strong round. One clinical scenario tripped you \\u2014 the debrief will lock it in.'],\n [3, 'Good base. Q1 (digoxin + haemodialysis) and Q4 (thiopentone redistribution) are the high-yield misses \\u2014 re-read both debriefs.'],\n [2, 'These are integrative questions \\u2014 they need the formula AND the clinical story. Go back to the debriefs and read each one fully.'],\n [0, 'Start with Q5 \\u2014 the bioavailability calculation is pure arithmetic. Once that clicks, tackle the clinical scenarios.']\n ];\n gid('verdict').textContent = verdicts[4][1];\n for (vi = 0; vi < verdicts.length; vi++) {\n if (c >= verdicts[vi][0]) {\n gid('verdict').innerHTML = verdicts[vi][1];\n break;\n }\n }\n\n gid('ct-c').textContent = '\\u2705 ' + c + ' Correct';\n gid('ct-w').textContent = '\\u274C ' + w + ' Wrong';\n gid('ct-s').textContent = '\\u23ED ' + s + ' Skipped';\n\n sc = gid('score');\n sc.style.display = 'block';\n sc.scrollIntoView({ behavior: 'smooth', block: 'center' });\n }\n\n function tryInit() {\n var sentinel = document.getElementById(NS + '-sentinel');\n var submit = document.getElementById(NS + '-submit');\n var retry = document.getElementById(NS + '-retry');\n if (!sentinel || !submit || !retry) {\n setTimeout(tryInit, 80);\n return;\n }\n submit.addEventListener('click', showScore);\n retry.addEventListener('click', function () {\n build();\n window.scrollTo(0, 0);\n });\n var bar = document.getElementById(NS + '-progress');\n if (bar && window.IntersectionObserver) {\n new IntersectionObserver(function (entries) {\n bar.className = entries[0].isIntersecting ? 'mr-progress' : 'mr-progress visible';\n }, { threshold: 0 }).observe(sentinel);\n }\n build();\n }\n\n tryInit();\n\n}());\n<\/script>\n\n<\/html>\n\n\n","protected":false},"excerpt":{"rendered":"<p>Morning Rounds \u00b7 Pharmacokinetics \u00b7 Round 06 Numerical Series · Pharmacokinetics Morning Rounds · Round 06 of 07 Mixed ClinicalNumericals Five scenarios · All concepts integrated — the way examiners actually ask them 5 Questions +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[74,79],"tags":[83],"class_list":["post-37352","post","type-post","status-publish","format-standard","hentry","category-morning-rounds","category-pharmacology","tag-neet-pg"],"yoast_head":"\n<title>Pharmacokinetics - Mixed Clinical Numericals - atsixty<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacokinetics - Mixed Clinical Numericals - atsixty\" \/>\n<meta property=\"og:description\" content=\"Morning Rounds \u00b7 Pharmacokinetics \u00b7 Round 06 Numerical Series · Pharmacokinetics Morning Rounds · Round 06 of 07 Mixed ClinicalNumericals Five scenarios · All concepts integrated — the way examiners actually ask them 5 Questions +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/\" \/>\n<meta property=\"og:site_name\" content=\"atsixty\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-23T05:05:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-23T05:05:48+00:00\" \/>\n<meta name=\"author\" content=\"Avi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/\"},\"author\":{\"name\":\"Avi\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"headline\":\"Pharmacokinetics – Mixed Clinical Numericals\",\"datePublished\":\"2026-08-23T05:05:07+00:00\",\"dateModified\":\"2026-08-23T05:05:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/\"},\"wordCount\":49,\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"keywords\":[\"NEET-PG\"],\"articleSection\":[\"Morning Rounds\",\"Pharmacology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/\",\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/\",\"name\":\"Pharmacokinetics - Mixed Clinical Numericals - atsixty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\"},\"datePublished\":\"2026-08-23T05:05:07+00:00\",\"dateModified\":\"2026-08-23T05:05:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/atsixty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacokinetics – Mixed Clinical Numericals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\",\"url\":\"https:\\\/\\\/atsixty.com\\\/\",\"name\":\"At Sixty\",\"description\":\"The Option Taken\",\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atsixty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\",\"name\":\"Avi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"url\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"contentUrl\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"width\":200,\"height\":200,\"caption\":\"Avi\"},\"logo\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\"},\"sameAs\":[\"https:\\\/\\\/atsixty.com\"],\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/author\\\/avinaux\\\/\"}]}<\/script>\n","yoast_head_json":{"title":"Pharmacokinetics - Mixed Clinical Numericals - atsixty","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/","og_locale":"en_US","og_type":"article","og_title":"Pharmacokinetics - Mixed Clinical Numericals - atsixty","og_description":"Morning Rounds \u00b7 Pharmacokinetics \u00b7 Round 06 Numerical Series · Pharmacokinetics Morning Rounds · Round 06 of 07 Mixed ClinicalNumericals Five scenarios · All concepts integrated — the way examiners actually ask them 5 Questions +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round","og_url":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/","og_site_name":"atsixty","article_published_time":"2026-08-23T05:05:07+00:00","article_modified_time":"2026-08-23T05:05:48+00:00","author":"Avi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/#article","isPartOf":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/"},"author":{"name":"Avi","@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"headline":"Pharmacokinetics – Mixed Clinical Numericals","datePublished":"2026-08-23T05:05:07+00:00","dateModified":"2026-08-23T05:05:48+00:00","mainEntityOfPage":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/"},"wordCount":49,"publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"keywords":["NEET-PG"],"articleSection":["Morning Rounds","Pharmacology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/","url":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/","name":"Pharmacokinetics - Mixed Clinical Numericals - atsixty","isPartOf":{"@id":"https:\/\/atsixty.com\/#website"},"datePublished":"2026-08-23T05:05:07+00:00","dateModified":"2026-08-23T05:05:48+00:00","breadcrumb":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atsixty.com\/"},{"@type":"ListItem","position":2,"name":"Pharmacokinetics – Mixed Clinical Numericals"}]},{"@type":"WebSite","@id":"https:\/\/atsixty.com\/#website","url":"https:\/\/atsixty.com\/","name":"At Sixty","description":"The Option Taken","publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atsixty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d","name":"Avi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","url":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","contentUrl":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","width":200,"height":200,"caption":"Avi"},"logo":{"@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png"},"sameAs":["https:\/\/atsixty.com"],"url":"https:\/\/atsixty.com\/index.php\/author\/avinaux\/"}]}},"_links":{"self":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/comments?post=37352"}],"version-history":[{"count":2,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37352\/revisions"}],"predecessor-version":[{"id":37354,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37352\/revisions\/37354"}],"wp:attachment":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/media?parent=37352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/categories?post=37352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/tags?post=37352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}

{"id":37352,"date":"2026-08-23T10:35:07","date_gmt":"2026-08-23T05:05:07","guid":{"rendered":"https:\/\/atsixty.com\/?p=37352"},"modified":"2026-08-23T10:35:48","modified_gmt":"2026-08-23T05:05:48","slug":"pharmacokinetics-mixed-clinical-numericals","status":"publish","type":"post","link":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/","title":{"rendered":"Pharmacokinetics – Mixed Clinical Numericals"},"content":{"rendered":"\n\n\n\n\n\n\n\nMorning Rounds \u00b7 Pharmacokinetics \u00b7 Round 06<\/title>\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Playfair+Display:ital,wght@0,400;0,600;0,700;1,400;1,600&family=Source+Serif+4:ital,wght@0,300;0,400;0,600;1,400&display=swap\" rel=\"stylesheet\">\n<style>\n#npk06 *,#npk06 *::before,#npk06 *::after{box-sizing:border-box;margin:0;padding:0}\n#npk06{\n --ob:#1A5F7A;--ob-light:#236E8C;--ob-pale:#E6F3F7;--ob-dark:#114455;\n --correct:#2D6B47;--correct-bg:#EAF6EF;--correct-border:#3A9960;\n --wrong:#B83232;--wrong-bg:#FDF0F0;--wrong-border:#E53935;\n --ink:#0F2A35;--ink-mid:#2A4D5A;--ink-soft:#5A7D8A;\n --line:#B8D8E3;--cream:#F2F8FA;--warm:#F8FCFD;\n font-family:'Source Serif 4',Georgia,serif;\n font-size:16px;color:var(--ink);background:var(--cream);\n line-height:1.7;padding:0 0 64px;\n}\n#npk06 .mr-header{background:linear-gradient(135deg,var(--ob-dark) 0%,var(--ob) 60%,var(--ob-light) 100%);color:#E4F4F9;padding:36px 24px 30px;text-align:center;position:relative;overflow:hidden;}\n#npk06 .mr-header::before{content:'';position:absolute;inset:0;background:repeating-linear-gradient(45deg,transparent,transparent 18px,rgba(255,255,255,0.03) 18px,rgba(255,255,255,0.03) 19px);}\n#npk06 .mr-eyebrow{font-size:0.66rem;letter-spacing:0.22em;text-transform:uppercase;font-weight:700;opacity:0.6;margin-bottom:10px;position:relative;}\n#npk06 .mr-series-tag{display:inline-block;background:rgba(255,255,255,0.12);border:1px solid rgba(255,255,255,0.2);border-radius:4px;padding:2px 10px;font-size:0.64rem;letter-spacing:0.14em;text-transform:uppercase;font-weight:700;margin-bottom:14px;position:relative;}\n#npk06 .mr-title{font-family:'Playfair Display',serif;font-size:1.8rem;font-weight:700;line-height:1.2;margin-bottom:6px;position:relative;}\n#npk06 .mr-title em{font-style:italic;font-weight:400;opacity:0.85}\n#npk06 .mr-subtitle{font-size:0.82rem;opacity:0.65;margin-top:8px;font-style:italic;position:relative;}\n#npk06 .mr-chips{display:flex;justify-content:center;gap:10px;margin-top:18px;flex-wrap:wrap;position:relative;}\n#npk06 .mr-chip{background:rgba(255,255,255,0.13);border:1px solid rgba(255,255,255,0.22);border-radius:20px;padding:4px 13px;font-size:0.72rem;}\n#npk06 .mr-sentinel{height:1px}\n#npk06 .mr-progress{position:fixed;top:0;left:0;right:0;z-index:9999;background:var(--warm);border-bottom:1px solid var(--line);box-shadow:0 2px 12px rgba(15,42,53,0.1);padding:9px 16px;display:none;}\n#npk06 .mr-progress.visible{display:block}\n#npk06 .mr-prog-inner{max-width:720px;margin:0 auto;display:flex;align-items:center;justify-content:center}\n#npk06 .mr-pips{display:flex;align-items:center;justify-content:center}\n#npk06 .mr-pip-wrap{display:flex;align-items:center}\n#npk06 .mr-pip-line{width:28px;height:2px;background:var(--line);transition:background 0.35s}\n#npk06 .mr-pip-line.done{background:var(--ob)}\n#npk06 .mr-pip{width:28px;height:28px;border-radius:50%;border:2px solid var(--line);background:var(--warm);display:flex;align-items:center;justify-content:center;font-size:0.63rem;font-weight:700;color:var(--ink-soft);transition:all 0.3s;flex-shrink:0;}\n#npk06 .mr-pip.correct{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#npk06 .mr-pip.wrong{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#npk06 .mr-body{max-width:720px;margin:0 auto;padding:0 16px}\n#npk06 .mr-case{background:var(--warm);border:1px solid var(--line);border-left:4px solid var(--ob);border-radius:10px;margin:28px 0;overflow:hidden;box-shadow:0 1px 8px rgba(15,42,53,0.07);}\n#npk06 .mr-case-top{padding:16px 20px 14px;display:flex;gap:14px;align-items:flex-start}\n#npk06 .mr-num{font-family:'Playfair Display',serif;font-size:2.2rem;font-weight:700;color:var(--ob);opacity:0.14;line-height:1;margin-top:-2px;flex-shrink:0;}\n#npk06 .mr-meta{flex:1}\n#npk06 .mr-tag{font-size:0.61rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;color:var(--ob);opacity:0.8;margin-bottom:5px;}\n#npk06 .mr-stem{font-size:0.94rem;color:var(--ink);line-height:1.72}\n#npk06 .mr-stem strong{font-weight:600}\n#npk06 .mr-stem em{font-style:italic}\n#npk06 .mr-rule{height:1px;background:var(--line);margin:0 20px}\n#npk06 .mr-opts{padding:12px 20px 16px;display:flex;flex-direction:column;gap:8px}\n#npk06 .mr-opt{display:flex;align-items:flex-start;gap:11px;padding:10px 14px;border:1.5px solid var(--line);border-radius:8px;cursor:pointer;background:var(--warm);transition:border-color 0.15s,background 0.15s;-webkit-tap-highlight-color:transparent;}\n#npk06 .mr-opt:hover{border-color:var(--ob);background:var(--ob-pale)}\n#npk06 .mr-opt.locked{cursor:default}\n#npk06 .mr-opt.locked:hover{border-color:var(--line);background:var(--warm)}\n#npk06 .mr-opt.correct{border-color:var(--correct-border);background:var(--correct-bg);cursor:default}\n#npk06 .mr-opt.correct:hover{border-color:var(--correct-border);background:var(--correct-bg)}\n#npk06 .mr-opt.wrong{border-color:var(--wrong-border);background:var(--wrong-bg);cursor:default}\n#npk06 .mr-opt.wrong:hover{border-color:var(--wrong-border);background:var(--wrong-bg)}\n#npk06 .mr-opt.dimmed{opacity:0.35;cursor:default}\n#npk06 .mr-opt.dimmed:hover{border-color:var(--line);background:var(--warm)}\n#npk06 .mr-ltr{flex-shrink:0;width:20px;height:20px;border-radius:50%;border:1.5px solid var(--line);display:flex;align-items:center;justify-content:center;font-size:0.62rem;font-weight:700;color:var(--ink-soft);margin-top:2px;transition:all 0.15s;}\n#npk06 .mr-opt.correct .mr-ltr{background:var(--correct-border);border-color:var(--correct-border);color:#fff}\n#npk06 .mr-opt.wrong .mr-ltr{background:var(--wrong-border);border-color:var(--wrong-border);color:#fff}\n#npk06 .mr-opt-text{font-size:0.9rem;color:var(--ink-mid);line-height:1.58}\n#npk06 .mr-opt.correct .mr-opt-text{color:var(--correct);font-weight:600}\n#npk06 .mr-opt.wrong .mr-opt-text{color:var(--wrong)}\n#npk06 .mr-exp{display:none;border-top:1px solid #9CCFDF;background:linear-gradient(180deg,#D4EEF7 0%,#EAF5FA 100%);padding:13px 20px 15px;}\n#npk06 .mr-exp-lbl{font-size:0.61rem;font-weight:700;letter-spacing:0.14em;text-transform:uppercase;color:var(--ob-dark);margin-bottom:6px;}\n#npk06 .mr-exp-text{font-size:0.86rem;color:#0F2A35;line-height:1.7}\n#npk06 .mr-exp-text strong{font-weight:600}\n#npk06 .mr-exp-text em{font-style:italic}\n#npk06 .mr-exp-text .calc{display:block;background:rgba(26,95,122,0.08);border-left:3px solid var(--ob);border-radius:0 4px 4px 0;padding:6px 10px;margin:8px 0;font-family:Georgia,serif;font-size:0.84rem;color:var(--ob-dark);}\n#npk06 .mr-submit-wrap{text-align:center;padding:28px 16px 8px}\n#npk06 .mr-btn{background:var(--ob);color:#E4F4F9;border:none;border-radius:8px;padding:13px 44px;font-family:'Playfair Display',serif;font-size:1rem;font-weight:700;cursor:pointer;box-shadow:0 2px 10px rgba(26,95,122,0.32);}\n#npk06 .mr-btn:hover{background:var(--ob-dark)}\n#npk06 .mr-score{display:none;background:var(--warm);border:1px solid var(--line);border-top:4px solid var(--ob);border-radius:10px;margin:24px 0 0;box-shadow:0 2px 12px rgba(15,42,53,0.08);overflow:hidden;}\n#npk06 .mr-score-in{padding:28px 24px;text-align:center}\n#npk06 .mr-score-ey{font-size:0.66rem;letter-spacing:0.14em;text-transform:uppercase;color:var(--ink-soft);margin-bottom:12px;font-weight:600;}\n#npk06 .mr-ring{width:98px;height:98px;border-radius:50%;background:conic-gradient(var(--ob) 0%,var(--line) 0%);display:flex;align-items:center;justify-content:center;margin:0 auto 16px;position:relative;}\n#npk06 .mr-ring::before{content:'';position:absolute;width:76px;height:76px;border-radius:50%;background:var(--warm);}\n#npk06 .mr-ring-in{position:relative;display:flex;flex-direction:column;align-items:center;line-height:1.2}\n#npk06 .mr-ring-pct{font-family:'Playfair Display',serif;font-size:1.3rem;font-weight:700;color:var(--ob)}\n#npk06 .mr-ring-sub{font-size:0.54rem;color:var(--ink-soft);text-transform:uppercase;letter-spacing:0.06em}\n#npk06 .mr-score-title{font-family:'Playfair Display',serif;font-size:1.15rem;font-weight:700;color:var(--ink);margin-bottom:4px}\n#npk06 .mr-score-net{font-size:0.9rem;color:var(--ob);font-weight:600;margin-bottom:4px}\n#npk06 .mr-verdict{font-size:0.83rem;color:var(--ink-soft);font-style:italic;margin-bottom:18px;padding:0 12px}\n#npk06 .mr-bands{display:flex;justify-content:center;gap:10px;flex-wrap:wrap}\n#npk06 .mr-band{padding:5px 13px;border-radius:16px;font-size:0.78rem;font-weight:600}\n#npk06 .mr-band-c{background:var(--correct-bg);color:var(--correct)}\n#npk06 .mr-band-w{background:var(--wrong-bg);color:var(--wrong)}\n#npk06 .mr-band-s{background:var(--ob-pale);color:var(--ob)}\n#npk06 .mr-retry{display:block;margin:18px auto 4px;background:transparent;border:2px solid var(--ob);color:var(--ob);border-radius:8px;padding:9px 28px;font-family:'Playfair Display',serif;font-size:0.92rem;font-weight:700;cursor:pointer;}\n#npk06 .mr-retry:hover{background:var(--ob);color:#E4F4F9}\n@media(max-width:480px){\n #npk06 .mr-title{font-size:1.4rem}\n #npk06 .mr-num{font-size:1.7rem}\n #npk06 .mr-stem{font-size:0.9rem}\n #npk06 .mr-opt-text{font-size:0.86rem}\n}\n<\/style>\n\n<div id=\"npk06\">\n\n <div class=\"mr-header\">\n <div class=\"mr-series-tag\">Numerical Series · Pharmacokinetics<\/div>\n <div class=\"mr-eyebrow\">Morning Rounds · Round 06 of 07<\/div>\n <div class=\"mr-title\">Mixed Clinical<br><em>Numericals<\/em><\/div>\n <div class=\"mr-subtitle\">Five scenarios · All concepts integrated — the way examiners actually ask them<\/div>\n <div class=\"mr-chips\">\n <span class=\"mr-chip\">5 Questions<\/span>\n <span class=\"mr-chip\">+4 \/ −1 scoring<\/span>\n <span class=\"mr-chip\">Options reshuffled<\/span>\n <\/div>\n <\/div>\n\n <div class=\"mr-sentinel\" id=\"npk06-sentinel\"><\/div>\n\n <div class=\"mr-progress\" id=\"npk06-progress\">\n <div class=\"mr-prog-inner\">\n <div class=\"mr-pips\" id=\"npk06-pips\"><\/div>\n <\/div>\n <\/div>\n\n <div class=\"mr-body\">\n <div id=\"npk06-cases\"><\/div>\n <div class=\"mr-submit-wrap\">\n <button class=\"mr-btn\" id=\"npk06-submit\">Submit for Debrief<\/button>\n <\/div>\n <div class=\"mr-score\" id=\"npk06-score\">\n <div class=\"mr-score-in\">\n <div class=\"mr-score-ey\">Round Complete<\/div>\n <div class=\"mr-ring\" id=\"npk06-ring\">\n <div class=\"mr-ring-in\">\n <span class=\"mr-ring-pct\" id=\"npk06-pct\">0%<\/span>\n <span class=\"mr-ring-sub\">net<\/span>\n <\/div>\n <\/div>\n <div class=\"mr-score-title\">Your Debrief<\/div>\n <div class=\"mr-score-net\" id=\"npk06-net\"><\/div>\n <div class=\"mr-verdict\" id=\"npk06-verdict\"><\/div>\n <div class=\"mr-bands\">\n <span class=\"mr-band mr-band-c\" id=\"npk06-ct-c\"><\/span>\n <span class=\"mr-band mr-band-w\" id=\"npk06-ct-w\"><\/span>\n <span class=\"mr-band mr-band-s\" id=\"npk06-ct-s\"><\/span>\n <\/div>\n <button class=\"mr-retry\" id=\"npk06-retry\">↻ New Round<\/button>\n <\/div>\n <\/div>\n <\/div>\n\n<\/div>\n\n<script>\n(function () {\n 'use strict';\n\n var NS = 'npk06';\n var TOTAL = 5;\n var MAX = 20;\n var LTRS = ['A','B','C','D'];\n\n var QS = [\n\n {\n id: 1,\n tag: 'Clinical Scenario — Digoxin Toxicity & Vd',\n stem: 'A 68-year-old man on digoxin develops toxicity. His plasma digoxin level is <strong>4 ng\/mL<\/strong> (toxic). Digoxin has a Vd of <strong>500 L<\/strong> and a half-life of <strong>36 hours<\/strong>. A colleague suggests urgent haemodialysis. You disagree. What is the total amount of digoxin in the body, and why is haemodialysis futile?',\n correct: '2000 mcg in the body; haemodialysis is futile because with Vd of 500 L, less than 1% of total body digoxin resides in plasma at any time \u2014 dialysis cannot access tissue-bound drug',\n opts: [\n '2000 mcg in the body; haemodialysis is futile because with Vd of 500 L, less than 1% of total body digoxin resides in plasma at any time \u2014 dialysis cannot access tissue-bound drug',\n '4 mcg in the body; haemodialysis is appropriate because the plasma concentration directly reflects total body burden and dialysis clears plasma efficiently',\n '2000 mcg in the body; haemodialysis is appropriate because digoxin\\'s long half-life of 36 hours means spontaneous elimination is too slow to be clinically useful',\n '200 mcg in the body; haemodialysis is futile but the correct treatment is forced diuresis to accelerate renal excretion of the plasma fraction'\n ],\n exp: 'First, calculate total body burden:<span class=\"calc\">Total drug = C<sub>p<\/sub> × Vd<br>= 4 ng\/mL × 500 L<br>= 4 ng\/mL × 500,000 mL<br>= 2,000,000 ng = <strong>2000 mcg = 2 mg<\/strong><\/span>Now ask: how much is in plasma?<span class=\"calc\">Plasma volume ≈ 3 L<br>Drug in plasma = 4 ng\/mL × 3000 mL = 12,000 ng = <strong>12 mcg<\/strong><br>That is 12 ÷ 2000 = <strong>0.6% of total body digoxin<\/strong><\/span>Haemodialysis filters plasma. With 99.4% of digoxin buried in tissues, dialysis removes a clinically irrelevant fraction. The correct treatment is <strong>digoxin-specific antibody fragments (Digibind\/DigiFab)<\/strong>, which bind digoxin in tissues and plasma, pulling it back into circulation for renal elimination. This question integrates Vd, unit conversion, and clinical reasoning in one scenario — exactly how exam writers think.'\n },\n\n {\n id: 2,\n tag: 'Clinical Scenario — Maintenance Dose Calculation',\n stem: 'A patient requires a plasma theophylline concentration of <strong>10 mg\/L<\/strong> at steady state. Theophylline clearance in this patient is <strong>40 mL\/min<\/strong> and its oral bioavailability is <strong>100%<\/strong>. What oral maintenance dose (in mg\/hour) is required?',\n correct: '24 mg\/hour',\n opts: [\n '24 mg\/hour',\n '400 mg\/hour',\n '0.4 mg\/hour',\n '14.4 mg\/hour'\n ],\n exp: 'Maintenance dose formula:<span class=\"calc\">Maintenance dose = C<sub>ss<\/sub> × CL ÷ F<br>where F = bioavailability (1.0 here)<\/span>Units first — the trap:<span class=\"calc\">CL = 40 mL\/min × 60 min\/hr = 2400 mL\/hr = <strong>2.4 L\/hr<\/strong><br><br>Maintenance dose = 10 mg\/L × 2.4 L\/hr ÷ 1.0<br>= <strong>24 mg\/hour<\/strong><\/span>Trap 400 mg\/hour comes from forgetting to convert mL to L (using 2400 instead of 2.4). Trap 0.4 mg\/hour divides instead of multiplies. Trap 14.4 mg\/hour uses 24 mL\/min (wrong conversion) × 0.6. The units conversion — mL\/min to L\/hr — is the entire exam point, identical to the infusion trap in R4. Examiners return to this well repeatedly because it catches the candidate who knows the formula but rushes the arithmetic.'\n },\n\n {\n id: 3,\n tag: 'Clinical Scenario — Phenytoin & Non-linear Kinetics',\n stem: 'A patient on phenytoin <strong>300 mg\/day<\/strong> has a plasma level of <strong>8 mg\/L<\/strong> (subtherapeutic; target 10–20 mg\/L). The dose is increased to <strong>400 mg\/day<\/strong>. Two weeks later the plasma level is <strong>24 mg\/L<\/strong> (toxic). Which pharmacokinetic property of phenytoin explains this disproportionate rise?',\n correct: 'Phenytoin follows Michaelis-Menten (saturation) kinetics; near therapeutic doses its metabolic enzymes are near-saturated, so a small dose increase causes a disproportionately large rise in plasma concentration',\n opts: [\n 'Phenytoin follows Michaelis-Menten (saturation) kinetics; near therapeutic doses its metabolic enzymes are near-saturated, so a small dose increase causes a disproportionately large rise in plasma concentration',\n 'Phenytoin has a narrow therapeutic index and the dose increase exceeded the LD50, causing toxic plasma levels through first-order accumulation',\n 'Phenytoin induces its own metabolism (autoinduction) at higher doses, paradoxically increasing plasma levels by generating toxic metabolites rather than clearing the parent compound',\n 'The rise is explained by zero-order kinetics at all phenytoin doses; a fixed absolute amount is always eliminated, so adding 100 mg\/day always raises steady state by a fixed predictable amount'\n ],\n exp: 'Phenytoin is the <em>classic<\/em> Michaelis-Menten drug. At low doses it behaves like first-order kinetics — enzymes not saturated, concentration proportional to dose. But near therapeutic levels, hepatic hydroxylation enzymes approach <strong>saturation<\/strong>.<span class=\"calc\">At saturation: elimination rate becomes fixed (zero-order-like)<br>Adding 100 mg\/day to an already-saturated system<br>= enzyme cannot keep up<br>= drug accumulates disproportionately<\/span>The dose increased by 33% (300 → 400 mg\/day). The plasma level increased by 200% (8 → 24 mg\/L). This <strong>non-linear<\/strong> response is the pharmacokinetic signature of Michaelis-Menten kinetics. Clinical rule: <strong>phenytoin dose adjustments must be small (25–50 mg increments) and levels rechecked after 2 weeks<\/strong>. Other MM drugs: aspirin (high dose), alcohol. Trap D is wrong: zero-order gives a <em>predictable<\/em> fixed rise — the unpredictability here is the whole point.'\n },\n\n {\n id: 4,\n tag: 'Clinical Scenario — Two-Compartment Kinetics',\n stem: 'An anaesthetist gives a single IV bolus of thiopentone. The patient loses consciousness within 30 seconds but wakes up in <strong>5–10 minutes<\/strong>, even though thiopentone has a terminal half-life of <strong>11 hours<\/strong>. The rapid recovery is best explained by:',\n correct: 'Rapid redistribution of thiopentone from the brain (central compartment) into muscle and fat (peripheral compartments), causing plasma and brain concentrations to fall below the threshold for unconsciousness despite the drug still being present in the body',\n opts: [\n 'Rapid redistribution of thiopentone from the brain (central compartment) into muscle and fat (peripheral compartments), causing plasma and brain concentrations to fall below the threshold for unconsciousness despite the drug still being present in the body',\n 'Rapid hepatic metabolism of thiopentone by CYP enzymes, eliminating the drug within minutes and explaining both the short duration of action and the 11-hour half-life being a measurement artefact',\n 'Active transport of thiopentone out of the CNS by P-glycoprotein efflux pumps at the blood-brain barrier, rapidly clearing the drug from the brain while total body burden remains unchanged',\n 'Tachyphylaxis to thiopentone developing within minutes of administration, causing GABA receptors in the brain to become desensitised and restoring consciousness before the drug is eliminated'\n ],\n exp: 'This is the <strong>redistribution phenomenon<\/strong> — one of the most elegant concepts in clinical pharmacokinetics.<br><br>After IV bolus, thiopentone rapidly enters the <strong>brain<\/strong> (highly perfused, lipophilic drug crosses BBB instantly) → unconsciousness. But the drug then <strong>redistributes<\/strong> from brain into <strong>muscle<\/strong> (large mass, moderately perfused) and eventually into <strong>fat<\/strong> (large mass, poorly perfused but high lipid affinity).<span class=\"calc\">Brain concentration falls → below anaesthetic threshold → patient wakes<br>Total body drug: unchanged (barely any eliminated in 10 min)<br>Terminal t½ 11 hrs = slow release back from fat + eventual hepatic metabolism<\/span>This two-compartment behaviour explains why thiopentone is used for <strong>induction only<\/strong>, not maintenance. The same principle explains why a single dose of diazepam has a shorter clinical effect than its 20–100 hour half-life would predict. Trap B is wrong: hepatic metabolism plays no role in the rapid offset. This is purely a distribution phenomenon.'\n },\n\n {\n id: 5,\n tag: 'Clinical Scenario — Bioavailability & Route Comparison',\n stem: 'A patient receives <strong>200 mg of drug X orally<\/strong> and achieves a peak plasma AUC of <strong>800 mg·hr\/L<\/strong>. The same patient receives <strong>100 mg IV<\/strong> and achieves an AUC of <strong>1000 mg·hr\/L<\/strong>. What is the <strong>oral bioavailability<\/strong> of Drug X?',\n correct: '40%',\n opts: [\n '40%',\n '80%',\n '125%',\n '50%'\n ],\n exp: 'Bioavailability (F) formula:<span class=\"calc\">F = (AUC<sub>oral<\/sub> ÷ Dose<sub>oral<\/sub>) ÷ (AUC<sub>IV<\/sub> ÷ Dose<sub>IV<\/sub>)<br><br>= (800 ÷ 200) ÷ (1000 ÷ 100)<br>= 4 ÷ 10<br>= <strong>0.40 = 40%<\/strong><\/span>The critical step: <strong>dose-normalise both AUCs before dividing<\/strong>. The doses are different (200 mg oral vs 100 mg IV), so raw AUC cannot be directly compared. Trap B (80%) comes from dividing 800 by 1000 without dose normalisation — the most common error. Trap C (125%) inverts the ratio after dose normalisation. Trap D (50%) divides 100 by 200 (the doses) without involving AUC at all.<br><br>Bioavailability of 40% is clinically significant: it means <strong>60% of the oral dose is lost<\/strong> to first-pass metabolism, gut wall metabolism, or incomplete absorption. To achieve the same systemic exposure as 100 mg IV, you would need 100 ÷ 0.40 = <strong>250 mg orally<\/strong>.'\n }\n\n ];\n\n var answers = {}, answered = 0, shuffled = {}, done = false;\n\n function gid(s) { return document.getElementById(NS + '-' + s); }\n function byId(s) { return document.getElementById(s); }\n\n function shuffleArr(arr) {\n var a = arr.slice(), i, j, t;\n for (i = a.length - 1; i > 0; i--) {\n j = Math.floor(Math.random() * (i + 1));\n t = a[i]; a[i] = a[j]; a[j] = t;\n }\n return a;\n }\n\n function countVal(v) {\n var n = 0, k;\n for (k in answers) { if (answers[k] === v) n++; }\n return n;\n }\n\n function buildPips() {\n var cont = gid('pips'), i, q, wLine, wPip, line, pip;\n cont.innerHTML = '';\n for (i = 0; i < QS.length; i++) {\n q = QS[i];\n if (i > 0) {\n wLine = document.createElement('div');\n wLine.className = 'mr-pip-wrap';\n line = document.createElement('div');\n line.className = 'mr-pip-line';\n line.id = NS + '-pl' + q.id;\n wLine.appendChild(line);\n cont.appendChild(wLine);\n }\n wPip = document.createElement('div');\n wPip.className = 'mr-pip-wrap';\n pip = document.createElement('div');\n pip.className = 'mr-pip';\n pip.id = NS + '-pip' + q.id;\n pip.textContent = String(q.id);\n wPip.appendChild(pip);\n cont.appendChild(wPip);\n }\n }\n\n function build() {\n var cont, i, q, opts, card, top, numDiv, meta, tag, stem,\n rule, optsDiv, expDiv, lbl, txt, j, optEl, ltrSpan, txtSpan;\n\n cont = gid('cases');\n cont.innerHTML = '';\n answers = {}; answered = 0; shuffled = {}; done = false;\n gid('score').style.display = 'none';\n buildPips();\n\n for (i = 0; i < QS.length; i++) {\n q = QS[i];\n opts = shuffleArr(q.opts);\n shuffled[q.id] = opts;\n\n card = document.createElement('div');\n card.className = 'mr-case';\n\n top = document.createElement('div');\n top.className = 'mr-case-top';\n\n numDiv = document.createElement('div');\n numDiv.className = 'mr-num';\n numDiv.textContent = q.id < 10 ? '0' + q.id : String(q.id);\n\n meta = document.createElement('div');\n meta.className = 'mr-meta';\n\n tag = document.createElement('div');\n tag.className = 'mr-tag';\n tag.innerHTML = q.tag;\n\n stem = document.createElement('div');\n stem.className = 'mr-stem';\n stem.innerHTML = q.stem;\n\n meta.appendChild(tag);\n meta.appendChild(stem);\n top.appendChild(numDiv);\n top.appendChild(meta);\n card.appendChild(top);\n\n rule = document.createElement('div');\n rule.className = 'mr-rule';\n card.appendChild(rule);\n\n optsDiv = document.createElement('div');\n optsDiv.className = 'mr-opts';\n\n for (j = 0; j < opts.length; j++) {\n optEl = document.createElement('div');\n optEl.className = 'mr-opt';\n optEl.id = NS + '-o' + q.id + '-' + j;\n optEl.setAttribute('role', 'button');\n optEl.setAttribute('tabindex', '0');\n\n ltrSpan = document.createElement('span');\n ltrSpan.className = 'mr-ltr';\n ltrSpan.textContent = LTRS[j];\n\n txtSpan = document.createElement('span');\n txtSpan.className = 'mr-opt-text';\n txtSpan.innerHTML = opts[j];\n\n optEl.appendChild(ltrSpan);\n optEl.appendChild(txtSpan);\n optsDiv.appendChild(optEl);\n\n (function (qid, oi) {\n optEl.addEventListener('click', function () { pick(qid, oi); });\n }(q.id, j));\n }\n card.appendChild(optsDiv);\n\n expDiv = document.createElement('div');\n expDiv.className = 'mr-exp';\n expDiv.id = NS + '-exp' + q.id;\n\n lbl = document.createElement('div');\n lbl.className = 'mr-exp-lbl';\n lbl.textContent = 'Debrief';\n\n txt = document.createElement('div');\n txt.className = 'mr-exp-text';\n txt.innerHTML = q.exp;\n\n expDiv.appendChild(lbl);\n expDiv.appendChild(txt);\n card.appendChild(expDiv);\n cont.appendChild(card);\n }\n }\n\n function pick(qid, oi) {\n var q, opts, i, el, correct;\n if (answers[qid] !== undefined || done) return;\n\n q = null;\n for (i = 0; i < QS.length; i++) {\n if (QS[i].id === qid) { q = QS[i]; break; }\n }\n if (!q) return;\n\n opts = shuffled[qid];\n correct = (opts[oi] === q.correct);\n answers[qid] = correct ? 'c' : 'w';\n answered++;\n\n for (i = 0; i < opts.length; i++) {\n el = byId(NS + '-o' + qid + '-' + i);\n if (opts[i] === q.correct) {\n el.className = 'mr-opt correct locked';\n } else if (i === oi) {\n el.className = 'mr-opt wrong locked';\n } else {\n el.className = 'mr-opt dimmed locked';\n }\n }\n\n byId(NS + '-exp' + qid).style.display = 'block';\n byId(NS + '-pip' + qid).className = 'mr-pip ' + (correct ? 'correct' : 'wrong');\n\n if (qid > 1) {\n var pl = byId(NS + '-pl' + qid);\n if (pl) { pl.className = 'mr-pip-line done'; }\n }\n }\n\n function showScore() {\n var c, w, s, net, pct, disp, verdicts, vi, sc;\n if (done) return;\n done = true;\n\n c = countVal('c');\n w = countVal('w');\n s = TOTAL - answered;\n net = (c * 4) - w;\n pct = Math.max(0, Math.round((net \/ MAX) * 100));\n disp = Math.min(100, Math.max(0, pct));\n\n gid('ring').style.background =\n 'conic-gradient(#1A5F7A ' + disp + '%, #B8D8E3 0%)';\n\n gid('pct').textContent = pct + '%';\n gid('net').textContent = 'Net Score: ' + net + ' \/ ' + MAX;\n\n verdicts = [\n [5, 'Flawless. Digoxin toxicity, phenytoin saturation, thiopentone redistribution, bioavailability \\u2014 all integrated cleanly.'],\n [4, 'Strong round. One clinical scenario tripped you \\u2014 the debrief will lock it in.'],\n [3, 'Good base. Q1 (digoxin + haemodialysis) and Q4 (thiopentone redistribution) are the high-yield misses \\u2014 re-read both debriefs.'],\n [2, 'These are integrative questions \\u2014 they need the formula AND the clinical story. Go back to the debriefs and read each one fully.'],\n [0, 'Start with Q5 \\u2014 the bioavailability calculation is pure arithmetic. Once that clicks, tackle the clinical scenarios.']\n ];\n gid('verdict').textContent = verdicts[4][1];\n for (vi = 0; vi < verdicts.length; vi++) {\n if (c >= verdicts[vi][0]) {\n gid('verdict').innerHTML = verdicts[vi][1];\n break;\n }\n }\n\n gid('ct-c').textContent = '\\u2705 ' + c + ' Correct';\n gid('ct-w').textContent = '\\u274C ' + w + ' Wrong';\n gid('ct-s').textContent = '\\u23ED ' + s + ' Skipped';\n\n sc = gid('score');\n sc.style.display = 'block';\n sc.scrollIntoView({ behavior: 'smooth', block: 'center' });\n }\n\n function tryInit() {\n var sentinel = document.getElementById(NS + '-sentinel');\n var submit = document.getElementById(NS + '-submit');\n var retry = document.getElementById(NS + '-retry');\n if (!sentinel || !submit || !retry) {\n setTimeout(tryInit, 80);\n return;\n }\n submit.addEventListener('click', showScore);\n retry.addEventListener('click', function () {\n build();\n window.scrollTo(0, 0);\n });\n var bar = document.getElementById(NS + '-progress');\n if (bar && window.IntersectionObserver) {\n new IntersectionObserver(function (entries) {\n bar.className = entries[0].isIntersecting ? 'mr-progress' : 'mr-progress visible';\n }, { threshold: 0 }).observe(sentinel);\n }\n build();\n }\n\n tryInit();\n\n}());\n<\/script>\n\n<\/html>\n\n\n","protected":false},"excerpt":{"rendered":"<p>Morning Rounds \u00b7 Pharmacokinetics \u00b7 Round 06 Numerical Series · Pharmacokinetics Morning Rounds · Round 06 of 07 Mixed ClinicalNumericals Five scenarios · All concepts integrated — the way examiners actually ask them 5 Questions +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[74,79],"tags":[83],"class_list":["post-37352","post","type-post","status-publish","format-standard","hentry","category-morning-rounds","category-pharmacology","tag-neet-pg"],"yoast_head":"\n<title>Pharmacokinetics - Mixed Clinical Numericals - atsixty<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmacokinetics - Mixed Clinical Numericals - atsixty\" \/>\n<meta property=\"og:description\" content=\"Morning Rounds \u00b7 Pharmacokinetics \u00b7 Round 06 Numerical Series · Pharmacokinetics Morning Rounds · Round 06 of 07 Mixed ClinicalNumericals Five scenarios · All concepts integrated — the way examiners actually ask them 5 Questions +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/\" \/>\n<meta property=\"og:site_name\" content=\"atsixty\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-23T05:05:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-23T05:05:48+00:00\" \/>\n<meta name=\"author\" content=\"Avi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Avi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/\"},\"author\":{\"name\":\"Avi\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"headline\":\"Pharmacokinetics – Mixed Clinical Numericals\",\"datePublished\":\"2026-08-23T05:05:07+00:00\",\"dateModified\":\"2026-08-23T05:05:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/\"},\"wordCount\":49,\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"keywords\":[\"NEET-PG\"],\"articleSection\":[\"Morning Rounds\",\"Pharmacology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/\",\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/\",\"name\":\"Pharmacokinetics - Mixed Clinical Numericals - atsixty\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\"},\"datePublished\":\"2026-08-23T05:05:07+00:00\",\"dateModified\":\"2026-08-23T05:05:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/morning-rounds\\\/pharmacokinetics-mixed-clinical-numericals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/atsixty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacokinetics – Mixed Clinical Numericals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/#website\",\"url\":\"https:\\\/\\\/atsixty.com\\\/\",\"name\":\"At Sixty\",\"description\":\"The Option Taken\",\"publisher\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atsixty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/atsixty.com\\\/#\\\/schema\\\/person\\\/cf65e7ac7d8226d95c0bdf1036f7951d\",\"name\":\"Avi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"url\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"contentUrl\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\",\"width\":200,\"height\":200,\"caption\":\"Avi\"},\"logo\":{\"@id\":\"https:\\\/\\\/atsixty.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/logo-agency.png\"},\"sameAs\":[\"https:\\\/\\\/atsixty.com\"],\"url\":\"https:\\\/\\\/atsixty.com\\\/index.php\\\/author\\\/avinaux\\\/\"}]}<\/script>\n","yoast_head_json":{"title":"Pharmacokinetics - Mixed Clinical Numericals - atsixty","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/","og_locale":"en_US","og_type":"article","og_title":"Pharmacokinetics - Mixed Clinical Numericals - atsixty","og_description":"Morning Rounds \u00b7 Pharmacokinetics \u00b7 Round 06 Numerical Series · Pharmacokinetics Morning Rounds · Round 06 of 07 Mixed ClinicalNumericals Five scenarios · All concepts integrated — the way examiners actually ask them 5 Questions +4 \/ −1 scoring Options reshuffled Submit for Debrief Round Complete 0% net Your Debrief ↻ New Round","og_url":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/","og_site_name":"atsixty","article_published_time":"2026-08-23T05:05:07+00:00","article_modified_time":"2026-08-23T05:05:48+00:00","author":"Avi","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Avi","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/#article","isPartOf":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/"},"author":{"name":"Avi","@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"headline":"Pharmacokinetics – Mixed Clinical Numericals","datePublished":"2026-08-23T05:05:07+00:00","dateModified":"2026-08-23T05:05:48+00:00","mainEntityOfPage":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/"},"wordCount":49,"publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"keywords":["NEET-PG"],"articleSection":["Morning Rounds","Pharmacology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/","url":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/","name":"Pharmacokinetics - Mixed Clinical Numericals - atsixty","isPartOf":{"@id":"https:\/\/atsixty.com\/#website"},"datePublished":"2026-08-23T05:05:07+00:00","dateModified":"2026-08-23T05:05:48+00:00","breadcrumb":{"@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/atsixty.com\/index.php\/morning-rounds\/pharmacokinetics-mixed-clinical-numericals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/atsixty.com\/"},{"@type":"ListItem","position":2,"name":"Pharmacokinetics – Mixed Clinical Numericals"}]},{"@type":"WebSite","@id":"https:\/\/atsixty.com\/#website","url":"https:\/\/atsixty.com\/","name":"At Sixty","description":"The Option Taken","publisher":{"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atsixty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/atsixty.com\/#\/schema\/person\/cf65e7ac7d8226d95c0bdf1036f7951d","name":"Avi","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","url":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","contentUrl":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png","width":200,"height":200,"caption":"Avi"},"logo":{"@id":"https:\/\/atsixty.com\/wp-content\/uploads\/2025\/08\/logo-agency.png"},"sameAs":["https:\/\/atsixty.com"],"url":"https:\/\/atsixty.com\/index.php\/author\/avinaux\/"}]}},"_links":{"self":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/comments?post=37352"}],"version-history":[{"count":2,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37352\/revisions"}],"predecessor-version":[{"id":37354,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/posts\/37352\/revisions\/37354"}],"wp:attachment":[{"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/media?parent=37352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/categories?post=37352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atsixty.com\/index.php\/wp-json\/wp\/v2\/tags?post=37352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}